V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000269 | 230000156 | 1.63 | 79.3 | Palliative (P) | 2017-09-26 | 2017-09-26 | Capecitabine 5days + RT | 02 | N | 230000405 | CAPECITABINE |
| 230000270 | 230000157 | 1.6 | null | Adjuvant (A) | 2017-08-22 | 2017-08-27 | FLUOROURACIL | N | N | 230000413 | CAPECITABINE + OXALIPLATIN |
| 230000271 | 230000158 | 1.67 | 84.5 | Adjuvant (A) | null | 2015-02-08 | ABVD | N | N | 230000436 | CAPECITABINE + OXALIPLATIN |
| 230000272 | 230000159 | 1.7 | null | Curative (C) | 2015-09-03 | 2015-09-03 | Capecitabine | N | N | 230000455 | CAPECITABINE + OXALIPLATIN |
| 230000273 | 230000160 | 1.51 | 60.7 | Curative (C) | 2017-10-01 | 2017-10-09 | CHOP R | N | N | 230000475 | CAPECITABINE |
| 230000274 | 230000161 | 1.74 | 105.5 | Adjuvant (A) | 2015-02-01 | 2015-02-07 | CAPECITABINE + OXALIPLATIN | N | N | 230000526 | PANITUMUMAB |
| 230000275 | 230000162 | 1.65 | 57.4 | Curative (C) | 2014-07-27 | 2014-07-30 | Carboplatin + Etoposide iv&po | 02 | null | 230000532 | CAPECITABINE + RT |
| 230000276 | 230000163 | null | null | Adjuvant (A) | 2017-04-22 | 2017-04-27 | Cisplatin +Fluorouracil (3 wk) | N | N | 230000541 | CAPECITABINE + OXALIPLATIN |
| 230000277 | 230000164 | 1.63 | 69.799 | Adjuvant (A) | 2014-08-30 | 2014-08-31 | Capecitabine + Oxaliplatin 21day | N | N | 230000550 | SCOT TRIAL |
| 230000278 | 230000165 | 1.68 | 116.3 | Palliative (P) | 2017-08-18 | 2017-09-02 | Sorafenib | N | N | 230000560 | CAPECITABINE |
| 230000279 | 230000165 | 1.68 | 69 | Palliative (P) | 2017-07-19 | 2017-07-19 | Cisplatin + Pemetrexed | 02 | N | 230000560 | CAPECITABINE |
| 230000280 | 230000165 | 1.68 | 79 | Curative (C) | 2016-08-31 | 2016-09-15 | FLUOROURACIL + IRINOTECAN | N | N | 230000560 | OXALIPLATIN + MDG |
| 230000281 | 230000165 | 1.91 | 102.9 | null | 2017-05-20 | 2017-06-17 | Capecitabine + Oxaliplatin 21day | N | null | 230000560 | CAPECITABINE + OXALIPLATIN |
| 230000282 | 230000165 | 1.64 | 55.4 | Adjuvant (A) | 2017-03-13 | 2017-03-14 | GEFITINIB | 2 | N | 230000560 | CAPECITABINE + OXALIPLATIN |
| 230000283 | 230000165 | 1.68 | 63.2 | Adjuvant (A) | null | 2014-08-09 | Carboplatin AUC 6 - 10 | 2 | N | 230000560 | OXALIPLATIN + MDG |
| 230000284 | 230001748 | 1.64 | 75.4 | Neo-adjuvant (N) | null | 2017-10-23 | CAPECITABINE + RT | N | N | 230000676 | OXALIPLATIN + MDG |
| 230000285 | 230001751 | null | 64.2 | null | 2015-04-22 | 2015-04-22 | Trastuzumab 21 day maintenance | N | null | 230000691 | CAPECITABINE + OXALIPLATIN |
| 230000286 | 230001751 | 1.77 | 64.5 | Adjuvant (A) | 2015-08-21 | 2015-09-17 | Capecitabine + Oxaliplatin 21day | 2 | N | 230000691 | FLUOROURACIL |
| 230000287 | 230000166 | 1.55 | 57.4 | Adjuvant (A) | 2016-07-24 | 2016-08-07 | Fluorouracil + Folinic Acid Weekly | N | N | 230000700 | FLUOROURACIL |
| 230000288 | 230000167 | 1.52 | 58 | Curative (C) | 2016-02-03 | 2016-02-12 | Bevacizumab + CAPECITABINE + OXALIPLATIN | N | Y | 230000706 | CAPECITABINE |
| 230000289 | 230000168 | 1.64 | 73.6 | Disease modification (D) | 2013-11-22 | 2013-11-23 | CAPECITABINE + MITOMYCIN + RT | N | N | 230000766 | VANDETANIB |
| 230000290 | 230000169 | 1.7 | 70.1 | Curative (C) | 2013-05-27 | 2013-06-02 | Irinotecan | null | N | 230000786 | CAPE + CETUXIMAB + OXALIPLATIN |
| 230000291 | 230000170 | null | 51.2 | Disease modification (D) | 2018-05-12 | 2018-05-24 | VANDETANIB | null | N | 230000794 | CAPECITABINE + OXALIPLATIN |
| 230000292 | 230000171 | null | 61.5 | Not known (9) | 2014-09-16 | 2014-09-23 | Oxaliplatin + Modified de Gramont | 02 | null | 230000817 | CAPECITABINE |
| 230000293 | 230000172 | 1.61 | 0 | Palliative (P) | 2017-06-16 | 2017-06-20 | Capecitabine | N | N | 230000826 | FLUOROURACIL + RT |
| 230000294 | 230000172 | 1.77 | 81.08 | Palliative (P) | 2016-01-15 | 2016-02-01 | VANDETANIB | 02 | Y | 230000826 | CAPECITABINE |
| 230000295 | 230000173 | 1.56 | 64.2 | Adjuvant (A) | null | 2013-07-05 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 230000830 | CAPECITABINE + OXALIPLATIN |
| 230000296 | 230000174 | 1.54 | 75.3 | Curative (C) | 2015-09-12 | 2015-09-12 | Capecitabine + Oxaliplatin 21day | 02 | N | 230000889 | FLUOROURACIL + MITOMYCIN |
| 230000297 | 230000174 | 1.53 | 58.5 | Palliative (P) | 2013-09-05 | 2013-09-13 | CARBOPLATIN + PACLITAXEL | 2 | N | 230000889 | CAPECITABINE |
| 230000298 | 230000174 | null | 78.8 | Adjuvant (A) | 2015-12-08 | 2015-12-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | 2 | N | 230000889 | FLUOROURACIL + MITOMYCIN + RT |
| 230000299 | 230000174 | 1.7 | 91 | Adjuvant (A) | 2018-04-20 | 2018-04-27 | Amsacrine + FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | N | 230000889 | CAPECITABINE + OXALIPLATIN |
| 230000300 | 230000175 | 1.81 | 68.9 | Curative (C) | 2017-01-22 | 2017-01-22 | Capecitabine | 02 | N | 230000933 | OXALIPLATIN + MDG |
| 230000301 | 230000176 | 1.69 | 90.6 | Neo-adjuvant (N) | null | 2014-04-06 | Folfirinox | N | null | 230000970 | CAPECITABINE + MITOMYCIN |
| 230000302 | 230000177 | 1.78 | 67.9 | Palliative (P) | 2017-01-22 | 2017-01-25 | Cisplatin 7 day | 02 | N | 230000976 | CAPECITABINE |
| 230000303 | 230000178 | 1.75 | 70 | Adjuvant (A) | 2016-04-17 | 2016-04-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 230000981 | OXALIPLATIN + MDG |
| 230000304 | 230000179 | 1.8 | 88.2 | Neo-adjuvant (N) | 2013-06-08 | 2013-06-09 | Cisplatin | null | null | 230001000 | CAPECITABINE |
| 230000305 | 230000179 | 1.51 | 0 | Adjuvant (A) | 2014-09-21 | 2014-09-21 | Oxaliplatin + Modified de Gramont | 02 | N | 230001000 | CAPECITABINE + OXALIPLATIN |
| 230000306 | 230000179 | 1.76 | 66.7 | Adjuvant (A) | 2016-05-22 | 2016-06-26 | BCG Intravesical | null | N | 230001000 | CAPECITABINE + OXALIPLATIN |
| 230000307 | 230000179 | 1.64 | 86.8 | Disease modification (D) | 2015-07-01 | 2017-01-17 | Oxaliplatin + Modified de Gramont | N | N | 230001000 | OXALIPLATIN + MDG |
| 230000308 | 230000180 | 1.69 | 89 | Palliative (P) | 2017-10-11 | 2017-11-06 | Capecitabine + Oxaliplatin 21day | N | N | 230001059 | CAPECITABINE |
| 230000309 | 230000180 | 1.61 | 68 | Adjuvant (A) | 2016-09-03 | 2016-09-03 | AC | 02 | N | 230001059 | CAPECITABINE + RT |
| 230000310 | 230000181 | 1.71 | 122.6 | Neo-adjuvant (N) | 2018-01-18 | 2018-01-18 | Fluorouracil+Mitomycin+RT (Anal Ca) | 01 | 2 | 230001114 | OXALIPLATIN + MDG |
| 230000311 | 230000181 | null | 58.5 | Adjuvant (A) | 2016-02-17 | 2016-02-24 | Sorafenib | 02 | N | 230001114 | CAPECITABINE + OXALIPLATIN |
| 230000312 | 230001476 | 1.65 | null | Disease modification (D) | 2014-11-20 | 2014-11-22 | Capecitabine + Cisplatin | N | N | 230001188 | CAPECITABINE |
| 230000313 | 230001476 | 1.7 | 103.6 | Palliative (P) | 2015-10-16 | 2015-10-22 | Carboplatin + Etoposide iv&po | Y | N | 230001188 | CAPECITABINE + OXALIPLATIN |
| 230000314 | 230000182 | 0 | 68.1 | Adjuvant (A) | 2013-11-04 | 2013-11-04 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 230001202 | IRINOTECAN + MDG |
| 230000315 | 230000183 | 1.63 | 50 | null | 2014-10-03 | 2014-10-09 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | null | 230001226 | CAPECITABINE |
| 230000316 | 230000184 | 1.6 | 66 | Palliative (P) | 2018-12-03 | 2018-12-03 | IBRUTINIB | 02 | N | 230001261 | CAPECITABINE |
| 230000317 | 230000185 | 1.77 | 84.7 | Curative (C) | 2017-09-29 | 2017-10-13 | Capecitabine 35days + RT | 1 | Y | 230001275 | CTD |
| 230000318 | 230000186 | 1.73 | null | Curative (C) | 2017-02-28 | 2017-03-01 | Trial Unspecified | N | Y | 230001310 | OXALIPLATIN + MDG |